Notes - Finance Income And Finance Costs

SANTEN PHARMACEUTICAL CO.,LTD. - Filing #7254751

Concept 2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
Notes - Finance income and finance costs
Components of finance income and finance costs
Finance income
Interest income
Financial assets measured at amortized cost
1,027,000,000 JPY
446,000,000 JPY
Gain on valuation of derivatives
JPY
232,000,000 JPY
Other
107,000,000 JPY
30,000,000 JPY
Finance income
4,002,000,000 JPY
1,572,000,000 JPY
Finance costs
Interest expenses
Financial liabilities measured at amortized cost
716,000,000 JPY
574,000,000 JPY
Other
84,000,000 JPY
212,000,000 JPY
Finance costs
2,716,000,000 JPY
2,664,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.